PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.15 | Esr2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Esr2 | mm39_v1_chr12_-_76224025_76224039 | -0.28 | 1.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46146558 | 24.43 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr9_-_46146928 | 19.72 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr9_+_46179899 | 19.18 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr10_+_76411474 | 18.26 |
ENSMUST00000001183.8
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr10_+_87357782 | 14.29 |
ENSMUST00000219813.2
|
Pah
|
phenylalanine hydroxylase |
chr4_-_63072367 | 14.28 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr10_+_87357657 | 14.16 |
ENSMUST00000020241.17
|
Pah
|
phenylalanine hydroxylase |
chr3_+_94840352 | 13.83 |
ENSMUST00000090839.12
|
Selenbp1
|
selenium binding protein 1 |
chr11_+_102036356 | 13.62 |
ENSMUST00000055409.6
|
Nags
|
N-acetylglutamate synthase |
chr7_+_26819334 | 13.57 |
ENSMUST00000003100.10
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr6_-_6217021 | 13.21 |
ENSMUST00000015256.15
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr11_+_83637766 | 13.05 |
ENSMUST00000070832.3
|
Wfdc21
|
WAP four-disulfide core domain 21 |
chr7_+_127400016 | 13.02 |
ENSMUST00000106271.2
ENSMUST00000138432.2 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr9_-_22042930 | 12.75 |
ENSMUST00000213815.2
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr3_+_57332735 | 12.72 |
ENSMUST00000029377.8
|
Tm4sf4
|
transmembrane 4 superfamily member 4 |
chr6_-_6217126 | 12.67 |
ENSMUST00000188414.4
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr17_+_35780977 | 12.61 |
ENSMUST00000174525.8
ENSMUST00000068291.7 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr9_+_46151994 | 12.54 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr7_+_127399776 | 12.46 |
ENSMUST00000046863.12
ENSMUST00000206674.2 ENSMUST00000106272.8 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr19_+_31846154 | 12.34 |
ENSMUST00000224564.2
ENSMUST00000224304.2 ENSMUST00000075838.8 ENSMUST00000224400.2 |
A1cf
|
APOBEC1 complementation factor |
chr17_+_48571298 | 12.13 |
ENSMUST00000059873.14
ENSMUST00000154335.8 ENSMUST00000136272.8 ENSMUST00000125426.8 ENSMUST00000153420.2 |
Treml4
|
triggering receptor expressed on myeloid cells-like 4 |
chr12_-_113223839 | 12.13 |
ENSMUST00000194738.6
ENSMUST00000178282.3 |
Igha
|
immunoglobulin heavy constant alpha |
chr14_-_30645503 | 11.96 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr7_+_127399789 | 11.91 |
ENSMUST00000125188.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr10_+_127702326 | 11.85 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr6_+_71176811 | 11.77 |
ENSMUST00000067492.8
|
Fabp1
|
fatty acid binding protein 1, liver |
chr2_-_25391729 | 11.75 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr3_+_96736774 | 11.68 |
ENSMUST00000138014.8
|
Pdzk1
|
PDZ domain containing 1 |
chr7_-_140856642 | 11.45 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chrX_+_149330371 | 11.44 |
ENSMUST00000066337.13
ENSMUST00000112715.2 |
Alas2
|
aminolevulinic acid synthase 2, erythroid |
chr1_-_120001752 | 11.41 |
ENSMUST00000056089.8
|
Tmem37
|
transmembrane protein 37 |
chr10_+_75242745 | 11.29 |
ENSMUST00000039925.8
|
Upb1
|
ureidopropionase, beta |
chr7_-_105249308 | 11.27 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr11_-_5865124 | 10.90 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr7_-_12732067 | 10.88 |
ENSMUST00000032539.14
ENSMUST00000120903.8 |
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr11_+_75400889 | 10.87 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr1_+_131725119 | 10.82 |
ENSMUST00000112393.9
ENSMUST00000048660.12 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr10_-_128796834 | 10.59 |
ENSMUST00000026398.5
|
Mettl7b
|
methyltransferase like 7B |
chr2_+_172994841 | 10.50 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr15_+_76579885 | 10.45 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr9_-_22043083 | 10.43 |
ENSMUST00000069330.14
ENSMUST00000217643.2 |
Acp5
|
acid phosphatase 5, tartrate resistant |
chr18_+_60936910 | 10.36 |
ENSMUST00000097563.9
ENSMUST00000050487.16 ENSMUST00000167610.2 |
Cd74
|
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
chr1_-_162687369 | 10.27 |
ENSMUST00000193078.6
|
Fmo1
|
flavin containing monooxygenase 1 |
chr3_+_96736600 | 10.21 |
ENSMUST00000135031.8
|
Pdzk1
|
PDZ domain containing 1 |
chr9_+_51124983 | 10.17 |
ENSMUST00000034554.9
|
Pou2af1
|
POU domain, class 2, associating factor 1 |
chr17_-_33136021 | 10.11 |
ENSMUST00000054174.9
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr16_-_38115172 | 10.05 |
ENSMUST00000023504.5
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr7_-_48497771 | 9.91 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr15_-_82678490 | 9.90 |
ENSMUST00000006094.6
|
Cyp2d26
|
cytochrome P450, family 2, subfamily d, polypeptide 26 |
chr9_+_46180362 | 9.89 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr16_-_18880821 | 9.76 |
ENSMUST00000200568.2
|
Iglc1
|
immunoglobulin lambda constant 1 |
chr15_-_100579450 | 9.69 |
ENSMUST00000230740.2
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr5_+_35198853 | 9.63 |
ENSMUST00000030985.10
ENSMUST00000202573.2 |
Hgfac
|
hepatocyte growth factor activator |
chr17_+_84990541 | 9.60 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr18_-_32271224 | 9.52 |
ENSMUST00000234657.2
ENSMUST00000234386.2 ENSMUST00000234651.2 |
Proc
|
protein C |
chr1_+_88334678 | 9.52 |
ENSMUST00000027518.12
|
Spp2
|
secreted phosphoprotein 2 |
chr9_+_107957621 | 9.50 |
ENSMUST00000035211.14
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr19_+_4036562 | 9.36 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr10_+_128104525 | 9.19 |
ENSMUST00000050901.5
|
Apof
|
apolipoprotein F |
chr1_-_162687254 | 9.13 |
ENSMUST00000131058.8
|
Fmo1
|
flavin containing monooxygenase 1 |
chr10_-_128237087 | 9.08 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr9_+_107957640 | 9.02 |
ENSMUST00000162886.2
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr16_-_19019100 | 8.93 |
ENSMUST00000103749.3
|
Iglc2
|
immunoglobulin lambda constant 2 |
chr17_-_35077089 | 8.92 |
ENSMUST00000153400.8
|
Cfb
|
complement factor B |
chr2_+_126394327 | 8.81 |
ENSMUST00000061491.14
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr7_+_140343652 | 8.80 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr7_-_119122681 | 8.73 |
ENSMUST00000033267.4
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr11_+_75358866 | 8.72 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr6_-_70383976 | 8.72 |
ENSMUST00000103393.2
|
Igkv6-15
|
immunoglobulin kappa variable 6-15 |
chr5_-_145816774 | 8.71 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr7_+_127399848 | 8.70 |
ENSMUST00000139068.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr17_-_34219225 | 8.59 |
ENSMUST00000238098.2
ENSMUST00000087189.7 ENSMUST00000173075.3 ENSMUST00000172912.8 ENSMUST00000236740.2 ENSMUST00000025181.18 |
H2-K1
|
histocompatibility 2, K1, K region |
chr4_-_61972348 | 8.58 |
ENSMUST00000074018.4
|
Mup20
|
major urinary protein 20 |
chr5_+_146016064 | 8.57 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr3_+_82915031 | 8.57 |
ENSMUST00000048486.13
ENSMUST00000194175.2 |
Fgg
|
fibrinogen gamma chain |
chr12_-_57592907 | 8.55 |
ENSMUST00000044380.8
|
Foxa1
|
forkhead box A1 |
chr15_+_76579960 | 8.48 |
ENSMUST00000229679.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr10_+_87357816 | 8.46 |
ENSMUST00000218573.2
|
Pah
|
phenylalanine hydroxylase |
chr19_-_44017637 | 8.45 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr6_+_67838100 | 8.45 |
ENSMUST00000200586.2
ENSMUST00000103309.3 |
Igkv17-127
|
immunoglobulin kappa variable 17-127 |
chr17_-_84154173 | 8.43 |
ENSMUST00000000687.9
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr3_-_81883509 | 8.32 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr11_+_115353290 | 8.31 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr6_-_70194405 | 8.25 |
ENSMUST00000103384.2
|
Igkv8-24
|
immunoglobulin kappa chain variable 8-24 |
chr11_-_53313950 | 8.16 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr3_+_94600863 | 8.14 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chr4_+_20008357 | 8.11 |
ENSMUST00000117632.8
ENSMUST00000098244.2 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr17_+_25097199 | 8.10 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr11_-_89893707 | 8.07 |
ENSMUST00000020864.9
|
Pctp
|
phosphatidylcholine transfer protein |
chr7_+_28140352 | 8.03 |
ENSMUST00000078845.13
|
Gmfg
|
glia maturation factor, gamma |
chr17_-_56424265 | 8.03 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr8_+_123912976 | 8.02 |
ENSMUST00000019422.6
|
Dpep1
|
dipeptidase 1 |
chr6_-_70237939 | 7.97 |
ENSMUST00000103386.3
|
Igkv6-23
|
immunoglobulin kappa variable 6-23 |
chr4_-_49549489 | 7.97 |
ENSMUST00000029987.10
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr17_-_57535003 | 7.93 |
ENSMUST00000177046.2
ENSMUST00000024988.15 |
C3
|
complement component 3 |
chr5_-_87240405 | 7.89 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr14_+_14475188 | 7.88 |
ENSMUST00000026315.8
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr1_-_184543367 | 7.88 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr5_-_147259245 | 7.88 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr9_+_21746785 | 7.83 |
ENSMUST00000058777.8
|
Angptl8
|
angiopoietin-like 8 |
chr7_+_27147475 | 7.81 |
ENSMUST00000133750.8
|
Blvrb
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr14_-_47426863 | 7.80 |
ENSMUST00000089959.7
|
Gch1
|
GTP cyclohydrolase 1 |
chr10_-_39901249 | 7.78 |
ENSMUST00000163705.3
|
Mfsd4b1
|
major facilitator superfamily domain containing 4B1 |
chr2_+_24970327 | 7.76 |
ENSMUST00000044078.10
ENSMUST00000114380.9 |
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr17_-_84990360 | 7.74 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr14_-_30645711 | 7.73 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr10_+_59239466 | 7.72 |
ENSMUST00000009790.14
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr14_-_63654478 | 7.71 |
ENSMUST00000014597.5
|
Blk
|
B lymphoid kinase |
chrX_-_47602395 | 7.58 |
ENSMUST00000114945.9
ENSMUST00000037349.8 |
Aifm1
|
apoptosis-inducing factor, mitochondrion-associated 1 |
chr4_-_63073028 | 7.57 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr19_-_4548602 | 7.54 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr6_-_5256282 | 7.54 |
ENSMUST00000031773.9
|
Pon3
|
paraoxonase 3 |
chr1_+_93062962 | 7.52 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr5_-_87054796 | 7.50 |
ENSMUST00000031181.16
ENSMUST00000113333.2 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr8_+_105460627 | 7.48 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr11_-_106205320 | 7.46 |
ENSMUST00000167143.2
|
Cd79b
|
CD79B antigen |
chr4_-_61437704 | 7.43 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr9_-_44714263 | 7.39 |
ENSMUST00000044694.8
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr19_-_7218512 | 7.39 |
ENSMUST00000025675.11
|
Naa40
|
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
chr3_+_96432479 | 7.38 |
ENSMUST00000049208.11
|
Hjv
|
hemojuvelin BMP co-receptor |
chr9_-_70859418 | 7.33 |
ENSMUST00000216798.2
|
Lipc
|
lipase, hepatic |
chr9_-_107971640 | 7.30 |
ENSMUST00000081309.13
ENSMUST00000191985.2 |
Apeh
|
acylpeptide hydrolase |
chr6_+_70192384 | 7.26 |
ENSMUST00000103383.3
|
Igkv6-25
|
immunoglobulin kappa chain variable 6-25 |
chr2_-_6217844 | 7.23 |
ENSMUST00000042658.5
|
Echdc3
|
enoyl Coenzyme A hydratase domain containing 3 |
chr7_+_43874854 | 7.13 |
ENSMUST00000206144.2
|
Klk1
|
kallikrein 1 |
chr12_+_8062331 | 7.12 |
ENSMUST00000171239.2
|
Apob
|
apolipoprotein B |
chr17_-_35081129 | 7.12 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr16_-_18884431 | 7.12 |
ENSMUST00000200235.2
|
Iglc3
|
immunoglobulin lambda constant 3 |
chr7_-_19415301 | 7.10 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr5_-_87572060 | 7.08 |
ENSMUST00000072818.6
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr7_+_28140450 | 7.08 |
ENSMUST00000135686.2
|
Gmfg
|
glia maturation factor, gamma |
chr7_+_26006594 | 7.05 |
ENSMUST00000098657.5
|
Cyp2a4
|
cytochrome P450, family 2, subfamily a, polypeptide 4 |
chr15_+_7159038 | 7.01 |
ENSMUST00000067190.12
ENSMUST00000164529.9 |
Lifr
|
LIF receptor alpha |
chr11_+_120421496 | 7.00 |
ENSMUST00000026119.8
|
Gcgr
|
glucagon receptor |
chr6_+_48653047 | 6.98 |
ENSMUST00000054050.5
|
Gimap9
|
GTPase, IMAP family member 9 |
chr5_-_145946408 | 6.97 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr4_+_62278932 | 6.96 |
ENSMUST00000084526.12
|
Slc31a1
|
solute carrier family 31, member 1 |
chr6_-_70051586 | 6.96 |
ENSMUST00000103377.3
|
Igkv6-32
|
immunoglobulin kappa variable 6-32 |
chr9_-_103107495 | 6.95 |
ENSMUST00000035158.16
|
Trf
|
transferrin |
chr11_-_5900019 | 6.93 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr7_-_3298243 | 6.91 |
ENSMUST00000108653.4
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr10_-_17823736 | 6.89 |
ENSMUST00000037879.8
|
Heca
|
hdc homolog, cell cycle regulator |
chr16_-_45975440 | 6.87 |
ENSMUST00000059524.7
|
Gm4737
|
predicted gene 4737 |
chr15_-_96953823 | 6.85 |
ENSMUST00000023101.10
|
Slc38a4
|
solute carrier family 38, member 4 |
chr17_-_35081456 | 6.84 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr6_+_90310252 | 6.83 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr7_-_126014027 | 6.83 |
ENSMUST00000032968.7
ENSMUST00000206325.2 |
Cd19
|
CD19 antigen |
chr6_-_136638926 | 6.82 |
ENSMUST00000032336.7
|
Plbd1
|
phospholipase B domain containing 1 |
chr11_-_69906171 | 6.81 |
ENSMUST00000018718.8
ENSMUST00000102574.10 |
Acadvl
|
acyl-Coenzyme A dehydrogenase, very long chain |
chr7_-_45887888 | 6.79 |
ENSMUST00000154292.9
ENSMUST00000078680.13 ENSMUST00000177212.8 ENSMUST00000009667.12 |
Ush1c
|
USH1 protein network component harmonin |
chr10_+_127637015 | 6.79 |
ENSMUST00000071646.2
|
Rdh16
|
retinol dehydrogenase 16 |
chr7_-_46392403 | 6.79 |
ENSMUST00000128088.4
|
Saa1
|
serum amyloid A 1 |
chr8_+_13087805 | 6.76 |
ENSMUST00000128418.8
ENSMUST00000152034.2 |
F10
|
coagulation factor X |
chr17_-_56424577 | 6.73 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chr2_-_179976458 | 6.71 |
ENSMUST00000015771.3
|
Gata5
|
GATA binding protein 5 |
chr16_+_22710134 | 6.68 |
ENSMUST00000231328.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr7_-_3848050 | 6.67 |
ENSMUST00000108615.10
ENSMUST00000119469.2 |
Pira2
|
paired-Ig-like receptor A2 |
chr7_+_43874752 | 6.63 |
ENSMUST00000075162.5
|
Klk1
|
kallikrein 1 |
chr12_+_104304631 | 6.61 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr2_-_69172944 | 6.59 |
ENSMUST00000102709.8
ENSMUST00000102710.10 ENSMUST00000180142.2 |
Abcb11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr6_+_90527762 | 6.57 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr1_-_180021218 | 6.56 |
ENSMUST00000159914.8
|
Coq8a
|
coenzyme Q8A |
chr8_-_106863521 | 6.56 |
ENSMUST00000115979.9
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr15_-_96929086 | 6.55 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr3_+_82933383 | 6.54 |
ENSMUST00000029630.15
ENSMUST00000166581.4 |
Fga
|
fibrinogen alpha chain |
chr13_-_63036096 | 6.53 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr18_+_36797113 | 6.50 |
ENSMUST00000036765.8
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr9_-_22041894 | 6.47 |
ENSMUST00000115315.3
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr17_-_34247016 | 6.47 |
ENSMUST00000236627.2
ENSMUST00000237759.2 ENSMUST00000045467.14 ENSMUST00000114303.4 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr6_-_124519240 | 6.46 |
ENSMUST00000159463.8
ENSMUST00000162844.2 ENSMUST00000160505.8 ENSMUST00000162443.8 |
C1s1
|
complement component 1, s subcomponent 1 |
chr9_-_107971729 | 6.45 |
ENSMUST00000193254.6
|
Apeh
|
acylpeptide hydrolase |
chr7_-_12731594 | 6.43 |
ENSMUST00000133977.3
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr2_-_5017526 | 6.37 |
ENSMUST00000027980.8
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor |
chr17_+_25023263 | 6.37 |
ENSMUST00000234372.2
ENSMUST00000024972.7 |
Meiob
|
meiosis specific with OB domains |
chr11_+_101258368 | 6.35 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr11_+_69856222 | 6.34 |
ENSMUST00000018713.13
|
Cldn7
|
claudin 7 |
chr7_-_140590605 | 6.33 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr4_-_141327146 | 6.31 |
ENSMUST00000141518.8
ENSMUST00000127455.8 ENSMUST00000105784.8 |
Fblim1
|
filamin binding LIM protein 1 |
chr7_+_119125546 | 6.30 |
ENSMUST00000207387.2
ENSMUST00000207813.2 |
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr6_-_69792108 | 6.28 |
ENSMUST00000103367.3
|
Igkv12-44
|
immunoglobulin kappa variable 12-44 |
chr17_-_32639936 | 6.28 |
ENSMUST00000170392.9
ENSMUST00000237165.2 ENSMUST00000235892.2 ENSMUST00000114455.3 |
Pglyrp2
|
peptidoglycan recognition protein 2 |
chrX_+_72760183 | 6.22 |
ENSMUST00000002084.14
|
Abcd1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
chr4_-_131802561 | 6.21 |
ENSMUST00000105970.8
ENSMUST00000105975.8 |
Epb41
|
erythrocyte membrane protein band 4.1 |
chr9_+_107445101 | 6.19 |
ENSMUST00000192887.6
ENSMUST00000195752.6 |
Hyal2
|
hyaluronoglucosaminidase 2 |
chr1_-_120432669 | 6.18 |
ENSMUST00000027639.8
|
Marco
|
macrophage receptor with collagenous structure |
chr7_+_119125443 | 6.17 |
ENSMUST00000207440.2
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr2_+_163334238 | 6.16 |
ENSMUST00000109416.3
|
R3hdml
|
R3H domain containing-like |
chr6_-_124710084 | 6.16 |
ENSMUST00000112484.10
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr8_+_27750349 | 6.14 |
ENSMUST00000033880.7
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1 |
chr10_+_98943999 | 6.13 |
ENSMUST00000161240.4
|
Galnt4
|
polypeptide N-acetylgalactosaminyltransferase 4 |
chr9_-_103099262 | 6.13 |
ENSMUST00000170904.2
|
Trf
|
transferrin |
chr18_-_35760260 | 6.12 |
ENSMUST00000025212.8
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr11_-_78313043 | 6.12 |
ENSMUST00000001122.6
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr9_-_103107460 | 6.12 |
ENSMUST00000165296.8
ENSMUST00000112645.8 |
Trf
|
transferrin |
chr9_-_106035308 | 6.11 |
ENSMUST00000159809.2
ENSMUST00000162562.2 ENSMUST00000036382.13 |
Glyctk
|
glycerate kinase |
chr5_-_137919873 | 6.07 |
ENSMUST00000031741.8
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr9_+_57604895 | 6.06 |
ENSMUST00000034865.6
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr12_+_111409087 | 6.03 |
ENSMUST00000109792.8
|
Tnfaip2
|
tumor necrosis factor, alpha-induced protein 2 |
chr7_+_67925718 | 6.03 |
ENSMUST00000210558.2
|
Fam169b
|
family with sequence similarity 169, member B |
chr14_+_30608433 | 6.02 |
ENSMUST00000120269.11
ENSMUST00000078490.14 ENSMUST00000006703.15 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 36.9 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
11.0 | 44.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
8.4 | 33.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
7.1 | 35.4 | GO:0006548 | histidine catabolic process(GO:0006548) |
6.2 | 18.7 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
5.8 | 17.3 | GO:0071846 | actin filament debranching(GO:0071846) |
5.6 | 16.9 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
5.5 | 16.6 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
5.4 | 43.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
5.0 | 15.1 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
4.7 | 23.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
4.5 | 22.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
4.3 | 21.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
4.3 | 17.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
4.3 | 47.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
4.3 | 12.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
4.3 | 12.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
4.2 | 20.9 | GO:1904970 | brush border assembly(GO:1904970) |
4.2 | 12.6 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.9 | 15.7 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.8 | 41.6 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.7 | 18.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
3.7 | 11.0 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
3.7 | 11.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
3.6 | 17.9 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
3.6 | 17.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.5 | 10.6 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
3.4 | 20.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
3.3 | 9.9 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
3.2 | 16.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
3.2 | 9.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
3.2 | 22.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.1 | 3.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
3.1 | 9.3 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
3.1 | 52.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.0 | 9.1 | GO:0060540 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
3.0 | 9.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
2.9 | 2.9 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
2.9 | 11.5 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.8 | 11.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.8 | 8.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.8 | 11.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
2.8 | 11.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
2.8 | 8.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
2.8 | 16.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.7 | 11.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.7 | 10.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.6 | 10.5 | GO:0034971 | histone H3-R17 methylation(GO:0034971) bile acid signaling pathway(GO:0038183) |
2.6 | 18.4 | GO:0046618 | drug export(GO:0046618) |
2.6 | 7.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.6 | 5.2 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
2.6 | 5.2 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
2.5 | 5.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
2.5 | 22.5 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
2.5 | 12.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
2.5 | 7.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.5 | 9.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
2.5 | 17.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.5 | 27.0 | GO:0015879 | carnitine transport(GO:0015879) |
2.4 | 31.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.4 | 4.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.4 | 9.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.3 | 9.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
2.3 | 6.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.3 | 9.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.3 | 18.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.3 | 11.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.3 | 4.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.2 | 6.6 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
2.1 | 15.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.1 | 6.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
2.1 | 14.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
2.1 | 6.3 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
2.1 | 16.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.1 | 8.2 | GO:0030091 | protein repair(GO:0030091) |
2.1 | 6.2 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
2.0 | 6.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
2.0 | 16.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.0 | 2.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
2.0 | 10.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.0 | 6.0 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
2.0 | 11.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.0 | 7.8 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
2.0 | 7.8 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
1.9 | 5.8 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
1.9 | 13.5 | GO:0060309 | elastin catabolic process(GO:0060309) |
1.9 | 5.7 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.9 | 13.2 | GO:0015886 | heme transport(GO:0015886) |
1.9 | 24.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.9 | 11.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.9 | 5.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.9 | 14.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.8 | 7.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.8 | 3.6 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.8 | 5.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
1.8 | 9.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.8 | 3.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.8 | 35.6 | GO:0017144 | drug metabolic process(GO:0017144) |
1.8 | 5.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.8 | 54.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.7 | 5.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
1.7 | 6.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.7 | 5.1 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
1.7 | 5.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.7 | 18.8 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.7 | 5.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
1.7 | 10.2 | GO:0001812 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.7 | 5.0 | GO:0030070 | insulin processing(GO:0030070) |
1.6 | 4.9 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
1.6 | 14.7 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.6 | 16.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.6 | 4.8 | GO:0002501 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
1.6 | 4.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.6 | 4.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.6 | 11.0 | GO:0033762 | response to glucagon(GO:0033762) |
1.6 | 6.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.5 | 9.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.5 | 3.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
1.5 | 9.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.5 | 6.0 | GO:0015811 | L-cystine transport(GO:0015811) |
1.5 | 8.9 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.5 | 3.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.5 | 2.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.5 | 4.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.4 | 4.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.4 | 8.6 | GO:0008355 | olfactory learning(GO:0008355) |
1.4 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.4 | 7.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.4 | 7.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.4 | 8.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.4 | 2.8 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.4 | 8.3 | GO:0060853 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.4 | 5.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
1.4 | 5.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.4 | 12.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.4 | 5.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.4 | 5.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.4 | 5.4 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
1.4 | 17.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.3 | 8.1 | GO:0070459 | prolactin secretion(GO:0070459) |
1.3 | 4.0 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
1.3 | 7.9 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.3 | 1.3 | GO:0072181 | mesonephric duct formation(GO:0072181) |
1.3 | 18.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
1.3 | 15.6 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
1.3 | 3.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.3 | 2.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.3 | 15.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.3 | 2.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.3 | 3.8 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.3 | 7.6 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.2 | 3.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
1.2 | 2.5 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
1.2 | 6.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.2 | 11.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.2 | 7.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.2 | 8.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
1.2 | 4.8 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.2 | 7.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.2 | 3.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.2 | 3.6 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
1.2 | 44.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.2 | 2.4 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.2 | 4.8 | GO:0010269 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
1.2 | 3.5 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.2 | 3.5 | GO:0019627 | urea metabolic process(GO:0019627) |
1.2 | 7.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.2 | 7.0 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
1.2 | 3.5 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
1.1 | 5.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.1 | 13.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 18.2 | GO:0046415 | urate metabolic process(GO:0046415) |
1.1 | 4.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.1 | 3.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.1 | 4.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
1.1 | 34.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.1 | 4.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.1 | 6.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.1 | 4.4 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
1.1 | 16.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.1 | 3.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 4.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.1 | 3.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.1 | 43.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 4.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.1 | 3.2 | GO:0030221 | basophil differentiation(GO:0030221) |
1.1 | 3.2 | GO:0097402 | neuroblast migration(GO:0097402) |
1.1 | 5.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 9.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 4.2 | GO:0090282 | positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
1.1 | 4.2 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
1.1 | 4.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.0 | 22.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
1.0 | 6.3 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.0 | 3.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.0 | 17.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.0 | 11.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.0 | 11.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.0 | 17.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.0 | 9.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 4.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.0 | 3.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.0 | 3.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.0 | 4.9 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 4.9 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.0 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.0 | 2.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.0 | 2.0 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
1.0 | 29.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.0 | 4.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.0 | 6.8 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 4.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.9 | 2.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.9 | 10.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.9 | 2.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.9 | 4.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 5.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.9 | 2.8 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
0.9 | 5.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.9 | 3.7 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 1.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.9 | 2.8 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.9 | 2.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.9 | 4.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 4.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.9 | 1.8 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.9 | 0.9 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.9 | 1.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.9 | 3.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.9 | 4.5 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.9 | 2.7 | GO:0006203 | dGTP catabolic process(GO:0006203) DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.9 | 9.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.9 | 3.6 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.9 | 3.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 123.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.9 | 14.2 | GO:0042407 | cristae formation(GO:0042407) |
0.9 | 1.8 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.9 | 7.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 4.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.9 | 3.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.9 | 2.6 | GO:0015881 | creatine transport(GO:0015881) |
0.9 | 13.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.9 | 4.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.9 | 3.5 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.9 | 5.2 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.9 | 0.9 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.9 | 5.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.9 | 4.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.9 | 2.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.9 | 7.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 2.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 7.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 6.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 3.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.8 | 3.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 2.5 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.8 | 2.5 | GO:0003192 | mitral valve formation(GO:0003192) |
0.8 | 2.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.8 | 4.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.8 | 2.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.8 | 5.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.8 | 6.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 2.5 | GO:0072347 | response to anesthetic(GO:0072347) |
0.8 | 1.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.8 | 1.6 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.8 | 4.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 3.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.8 | 2.4 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
0.8 | 3.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.8 | 2.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.8 | 4.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.8 | 2.4 | GO:0043366 | beta selection(GO:0043366) |
0.8 | 2.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 7.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.8 | 3.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.8 | 2.3 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
0.8 | 0.8 | GO:0003290 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
0.8 | 6.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 3.9 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.8 | 3.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.8 | 3.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.8 | 6.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 5.4 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 2.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 3.1 | GO:0017126 | nucleologenesis(GO:0017126) |
0.8 | 3.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.8 | 1.5 | GO:0018158 | protein oxidation(GO:0018158) |
0.8 | 5.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 2.3 | GO:0035702 | monocyte homeostasis(GO:0035702) |
0.8 | 6.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.8 | 18.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.7 | 4.5 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 1.5 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
0.7 | 2.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.7 | 2.9 | GO:0072014 | proximal tubule development(GO:0072014) |
0.7 | 8.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 5.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.7 | 2.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 12.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.7 | 5.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.7 | 3.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.7 | 1.4 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.7 | 2.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.7 | 1.4 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.7 | 3.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.7 | 2.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.7 | 2.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 6.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 2.1 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.7 | 2.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.7 | 2.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.7 | 2.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.7 | 2.1 | GO:1905223 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) epicardium morphogenesis(GO:1905223) |
0.7 | 6.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.7 | 7.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.7 | 4.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 4.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.7 | 2.6 | GO:0015793 | glycerol transport(GO:0015793) |
0.7 | 3.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 0.7 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.7 | 2.6 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.7 | 4.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.7 | 6.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.6 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 4.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.6 | 2.6 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.6 | 5.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.6 | 3.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 1.3 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) |
0.6 | 1.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 7.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.6 | 2.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.6 | 1.3 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.6 | 18.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.6 | 1.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.6 | 5.6 | GO:0061709 | reticulophagy(GO:0061709) |
0.6 | 3.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.6 | 3.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.6 | 2.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 3.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.6 | 2.5 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.6 | 1.9 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.6 | 8.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 9.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 4.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 11.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 5.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 7.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 10.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 8.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.6 | 6.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 3.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 4.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 1.2 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
0.6 | 5.9 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.6 | 3.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.6 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 2.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.6 | 3.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 4.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 5.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.6 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 4.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 1.8 | GO:0046032 | ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.6 | 4.1 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 2.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 2.9 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.6 | 4.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 3.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 2.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 5.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.6 | 1.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.6 | 6.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.6 | 2.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 5.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 4.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 36.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 1.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 1.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.6 | 4.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 2.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 3.4 | GO:0019042 | viral latency(GO:0019042) |
0.6 | 14.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 4.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.6 | 2.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 0.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.6 | 2.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 9.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.6 | 4.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.6 | 2.2 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.6 | 2.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 2.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.5 | 2.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.5 | 31.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.5 | 2.2 | GO:0015791 | polyol transport(GO:0015791) |
0.5 | 11.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 2.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 3.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 1.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 4.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 1.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.5 | 1.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.5 | 1.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 3.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 2.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.5 | 2.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 2.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 2.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.5 | 3.7 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.5 | 3.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 2.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 7.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 1.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 2.1 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.5 | 8.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.5 | 0.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.5 | 1.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.5 | 4.6 | GO:2000741 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 4.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.5 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 119.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.5 | 1.5 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.5 | 1.5 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.5 | 5.0 | GO:0021995 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.5 | 8.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 4.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 4.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.5 | 4.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 15.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 6.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.5 | 7.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 1.0 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.5 | 2.0 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.5 | 6.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 2.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 1.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 1.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.5 | 3.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.5 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 6.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 3.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 5.8 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.5 | 1.9 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.5 | 1.4 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.5 | 8.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 2.4 | GO:0009624 | response to nematode(GO:0009624) |
0.5 | 1.9 | GO:0048143 | astrocyte activation(GO:0048143) |
0.5 | 8.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.4 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.5 | 2.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 1.4 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.5 | 1.9 | GO:0007522 | visceral muscle development(GO:0007522) |
0.5 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 3.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 2.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 3.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 0.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 2.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 0.9 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.4 | 1.8 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.4 | 0.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 1.3 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.4 | 1.3 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.4 | 10.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 2.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 1.3 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 | 3.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 7.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 3.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 3.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 3.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 2.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 7.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 1.7 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.4 | 1.2 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.4 | 7.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 1.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.4 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.4 | 1.6 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 0.8 | GO:1902336 | positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.4 | 1.2 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.4 | 1.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.4 | 15.3 | GO:0030104 | water homeostasis(GO:0030104) |
0.4 | 1.2 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.4 | 2.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 1.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.6 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.4 | 2.0 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 4.4 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 4.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 4.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.4 | 3.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.4 | 1.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.4 | 1.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.4 | 1.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 10.8 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 8.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 1.9 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 1.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.4 | 0.8 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 2.3 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.4 | 6.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 | 1.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 3.0 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.4 | 20.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 1.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 3.4 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.4 | 3.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 42.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.4 | 1.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.4 | 6.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 1.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.4 | 3.7 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 2.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 1.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.4 | 5.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 1.1 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.4 | 4.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 3.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 2.1 | GO:0006071 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.4 | 1.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 2.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.4 | 4.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.3 | 1.4 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 16.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 1.4 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.3 | 6.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 1.7 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.3 | 3.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 13.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 3.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 9.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 2.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 5.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.3 | 3.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 1.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 4.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.7 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.3 | 2.0 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 2.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 3.6 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.3 | 2.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 3.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 3.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 4.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.3 | 3.8 | GO:0072376 | protein activation cascade(GO:0072376) |
0.3 | 5.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 1.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.3 | 0.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 1.5 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 1.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 3.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.5 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.9 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.3 | 0.9 | GO:0035037 | sperm entry(GO:0035037) |
0.3 | 0.6 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 0.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 1.5 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.3 | 5.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 9.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 2.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 1.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 2.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 4.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 2.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 2.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 4.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 2.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 2.6 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 2.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 6.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 1.4 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.3 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 0.9 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.3 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.6 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 4.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 4.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 12.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.8 | GO:0090367 | regulation of mRNA modification(GO:0090365) negative regulation of mRNA modification(GO:0090367) |
0.3 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 1.7 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.3 | 0.8 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.3 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.6 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.3 | 1.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.5 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.3 | 4.0 | GO:0072350 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.3 | 1.3 | GO:0043056 | forward locomotion(GO:0043056) |
0.3 | 3.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 1.9 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.3 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 14.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 4.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.3 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.3 | 2.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 1.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 3.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 2.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 3.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 1.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 0.8 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.3 | 0.8 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.3 | 1.0 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 1.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.3 | 3.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.3 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.3 | 10.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 1.0 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.3 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 1.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 2.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 1.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 6.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 8.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 4.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 2.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 2.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 4.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 2.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.2 | 0.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.7 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.2 | 0.7 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 2.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 2.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.7 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 0.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.2 | 3.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.8 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.2 | 7.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 3.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 2.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 2.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 1.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 2.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 3.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 1.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 7.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 4.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 3.9 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 1.7 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 5.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 1.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 1.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.2 | 0.6 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 1.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 3.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.2 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 2.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 2.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.8 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.2 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.7 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 3.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.8 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.4 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.8 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 11.5 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 2.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 7.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 1.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 3.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.9 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.2 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 2.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.2 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 1.4 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.2 | 0.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.2 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 4.0 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 1.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 0.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.2 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 5.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 2.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 1.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 2.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 2.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 6.0 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.2 | 1.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 2.4 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.5 | GO:0061646 | positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization(GO:0061646) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 1.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 1.7 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.2 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 4.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 2.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 0.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.5 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 5.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 1.5 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 1.9 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 3.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.1 | 3.8 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.1 | 4.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 2.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 1.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 2.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.4 | GO:0007309 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.1 | 1.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 1.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 2.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 3.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.1 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 1.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.4 | GO:0043032 | negative regulation of T-helper 1 type immune response(GO:0002826) positive regulation of macrophage activation(GO:0043032) |
0.1 | 1.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 2.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 3.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 1.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 1.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.9 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.1 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 6.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.4 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.1 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 3.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 2.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 4.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 3.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 2.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 1.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 15.1 | GO:0050817 | coagulation(GO:0050817) |
0.1 | 1.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 1.0 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.4 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.1 | 2.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 1.1 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 2.0 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.6 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.1 | 0.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.2 | GO:0051140 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 1.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 2.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.6 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.3 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.2 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.1 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.3 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.4 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.9 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 2.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.4 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 6.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 1.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.7 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.1 | 14.8 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.6 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 1.6 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 1.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0070781 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.0 | 0.2 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.2 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) C-5 methylation of cytosine(GO:0090116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 69.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
4.1 | 49.5 | GO:0042627 | chylomicron(GO:0042627) |
4.1 | 4.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
3.7 | 51.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.6 | 17.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.2 | 39.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.4 | 28.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.2 | 8.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
2.0 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.9 | 48.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.8 | 7.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.7 | 15.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.7 | 15.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 5.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.7 | 5.0 | GO:0044317 | rod spherule(GO:0044317) |
1.6 | 15.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 12.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.4 | 43.8 | GO:0031528 | microvillus membrane(GO:0031528) |
1.4 | 14.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 14.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
1.3 | 6.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.3 | 5.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.3 | 22.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 14.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.2 | 1.2 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.1 | 3.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
1.1 | 10.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.1 | 8.7 | GO:0061617 | MICOS complex(GO:0061617) |
1.1 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.1 | 32.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.1 | 7.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 270.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.1 | 11.6 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 4.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.0 | 8.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 1.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.0 | 3.8 | GO:0005745 | m-AAA complex(GO:0005745) |
1.0 | 1.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.9 | 28.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.9 | 2.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.9 | 4.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.9 | 3.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.9 | 2.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.8 | 6.8 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 3.4 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.8 | 11.7 | GO:0005902 | microvillus(GO:0005902) |
0.8 | 5.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 2.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.8 | 12.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 1.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.8 | 1.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.8 | 3.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.7 | 12.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.7 | 3.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.7 | 2.9 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.7 | 2.9 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.7 | 2.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 6.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.7 | 2.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.7 | 2.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 4.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 2.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 3.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 11.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 20.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 6.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 9.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 8.6 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 1.8 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 1.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.6 | 11.0 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 2.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 4.5 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 2.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 1.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.5 | 1.6 | GO:0031477 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
0.5 | 6.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 2.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 6.2 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 4.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.5 | 2.1 | GO:0008623 | CHRAC(GO:0008623) |
0.5 | 5.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 2.5 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.5 | 2.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.5 | 5.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 6.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 14.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 4.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 24.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 3.0 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 3.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 6.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 1.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.4 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 2.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 2.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 4.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 2.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 0.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.4 | 100.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 3.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 2.0 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.4 | 3.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 5.4 | GO:0061702 | inflammasome complex(GO:0061702) |
0.4 | 3.1 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 1.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.4 | 1.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.4 | 1.1 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.4 | 5.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 0.7 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.4 | 3.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 26.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 4.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 3.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 14.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 2.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 10.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 3.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 1.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 2.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 15.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 2.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 3.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 11.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 108.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 1.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 3.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 1.3 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.3 | 4.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 3.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0097632 | extrinsic component of pre-autophagosomal structure membrane(GO:0097632) |
0.2 | 4.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 4.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 146.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.7 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 1.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 4.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 3.2 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 3.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.4 | GO:0070160 | occluding junction(GO:0070160) |
0.2 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 4.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 4.2 | GO:0031430 | M band(GO:0031430) |
0.2 | 5.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 20.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 32.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 2.4 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 3.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0098644 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) complex of collagen trimers(GO:0098644) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 4.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 7.4 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 16.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 5.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 1.2 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 3.4 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 1.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 26.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 3.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 28.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 0.9 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 14.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 2.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 3.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.8 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.8 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.9 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 227.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 26.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.2 | GO:0000801 | central element(GO:0000801) |
0.1 | 24.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 7.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 10.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 2.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 3.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 16.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 10.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 16.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 3.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 2.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 3.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.9 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 3.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 77.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 3.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 2.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0097361 | MMXD complex(GO:0071817) CIA complex(GO:0097361) |
0.0 | 0.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 52.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 27.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 48.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
11.5 | 46.1 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
7.5 | 45.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
6.8 | 6.8 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
6.7 | 26.7 | GO:0019862 | IgA binding(GO:0019862) |
6.1 | 36.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
5.4 | 16.2 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
5.4 | 16.2 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
5.2 | 25.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
4.9 | 14.6 | GO:0004998 | transferrin receptor activity(GO:0004998) |
4.7 | 23.5 | GO:0035478 | chylomicron binding(GO:0035478) |
4.6 | 4.6 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
4.1 | 29.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.8 | 18.9 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
3.8 | 41.7 | GO:0032052 | bile acid binding(GO:0032052) |
3.8 | 11.4 | GO:0008431 | vitamin E binding(GO:0008431) |
3.7 | 22.3 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
3.6 | 14.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.5 | 10.6 | GO:0004001 | adenosine kinase activity(GO:0004001) |
3.5 | 10.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
3.5 | 24.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
3.4 | 13.5 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
3.4 | 10.1 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
3.3 | 13.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
3.3 | 9.9 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
3.2 | 25.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
3.0 | 54.2 | GO:0046977 | TAP binding(GO:0046977) |
3.0 | 9.0 | GO:0034632 | retinol transporter activity(GO:0034632) |
3.0 | 18.0 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
3.0 | 14.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
2.9 | 8.8 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
2.7 | 21.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
2.6 | 10.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
2.6 | 5.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
2.6 | 15.4 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 7.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.5 | 19.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
2.4 | 7.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
2.4 | 4.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
2.4 | 7.1 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
2.4 | 11.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.3 | 11.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
2.3 | 6.8 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
2.2 | 19.9 | GO:0035473 | lipase binding(GO:0035473) |
2.2 | 15.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
2.2 | 6.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
2.1 | 12.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.1 | 6.3 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
2.1 | 12.5 | GO:0034618 | arginine binding(GO:0034618) |
2.1 | 24.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.0 | 6.1 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
2.0 | 4.0 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
2.0 | 5.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.9 | 5.8 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.9 | 13.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.9 | 34.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.9 | 43.6 | GO:0019825 | oxygen binding(GO:0019825) |
1.9 | 11.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.8 | 32.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.8 | 5.3 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
1.7 | 15.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.7 | 10.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.7 | 31.0 | GO:0008430 | selenium binding(GO:0008430) |
1.7 | 5.2 | GO:0070540 | stearic acid binding(GO:0070540) |
1.7 | 5.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
1.7 | 11.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.7 | 8.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.6 | 3.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.6 | 29.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.6 | 8.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.6 | 6.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.6 | 9.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.6 | 6.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.6 | 11.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.6 | 7.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.6 | 4.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.5 | 9.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
1.5 | 4.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.5 | 4.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.5 | 6.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.5 | 14.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 4.5 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
1.5 | 5.8 | GO:0043532 | angiostatin binding(GO:0043532) |
1.5 | 4.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.4 | 4.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.4 | 4.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.4 | 7.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.4 | 7.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.4 | 57.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.4 | 2.8 | GO:0004067 | asparaginase activity(GO:0004067) |
1.4 | 13.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.4 | 9.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.4 | 5.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.4 | 6.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.3 | 2.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
1.3 | 7.9 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 6.5 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.3 | 13.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.3 | 3.9 | GO:0004454 | ketohexokinase activity(GO:0004454) |
1.3 | 15.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.3 | 29.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.3 | 12.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
1.2 | 39.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.2 | 4.8 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
1.2 | 3.6 | GO:0001761 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
1.2 | 4.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
1.2 | 4.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
1.2 | 3.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.2 | 3.5 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.2 | 9.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.2 | 10.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.2 | 9.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.1 | 32.0 | GO:0001848 | complement binding(GO:0001848) |
1.1 | 4.6 | GO:0042806 | fucose binding(GO:0042806) |
1.1 | 3.4 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
1.1 | 12.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.1 | 4.5 | GO:0051435 | BH4 domain binding(GO:0051435) |
1.1 | 17.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.1 | 2.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.1 | 6.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.1 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.1 | 15.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.1 | 4.4 | GO:0004103 | choline kinase activity(GO:0004103) |
1.1 | 6.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.1 | 3.2 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
1.1 | 2.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.1 | 8.6 | GO:0005186 | pheromone activity(GO:0005186) |
1.1 | 3.2 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.1 | 6.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 15.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 13.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.0 | 3.1 | GO:0004371 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
1.0 | 4.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.0 | 6.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.0 | 4.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 9.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.0 | 4.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.0 | 12.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 10.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.0 | 3.0 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
1.0 | 5.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 129.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 4.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.0 | 11.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.0 | 4.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.0 | 2.9 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
1.0 | 25.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.9 | 6.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.9 | 5.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.9 | 2.8 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.9 | 3.7 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 19.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.9 | 6.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.9 | 2.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.9 | 4.6 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.9 | 9.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.9 | 4.5 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.9 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 6.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.9 | 5.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 3.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 2.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.9 | 8.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 4.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.9 | 9.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 7.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 15.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.9 | 3.5 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.9 | 16.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.9 | 2.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.9 | 4.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 2.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.8 | 2.5 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.8 | 2.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.8 | 4.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.8 | 2.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 3.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 4.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.8 | 3.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.8 | 2.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.8 | 3.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.8 | 5.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 4.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 4.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 4.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 12.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.7 | 5.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.7 | 2.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.7 | 4.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 8.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 2.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.7 | 2.1 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.7 | 6.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 2.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 2.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.7 | 4.1 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 2.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.7 | 8.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 2.7 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.7 | 2.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 8.4 | GO:0015250 | water channel activity(GO:0015250) |
0.6 | 1.9 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.6 | 1.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.6 | 1.3 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.6 | 25.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.6 | 1.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.6 | 6.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 3.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 3.1 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.6 | 4.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 9.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.6 | 1.9 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.6 | 11.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 3.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 9.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 3.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.6 | 6.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 142.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 2.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.6 | 5.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 2.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 4.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.6 | 2.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.2 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 4.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 9.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.6 | 4.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 2.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.6 | 2.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.6 | 2.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 1.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.6 | 1.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 4.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 1.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 7.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 2.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 16.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 5.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 11.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.5 | 2.7 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 2.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.5 | 1.6 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.5 | 4.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 6.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 2.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.5 | 6.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 2.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.5 | 2.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.5 | 3.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 1.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.5 | 5.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 6.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 6.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 1.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.5 | 2.0 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 2.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.0 | GO:0032093 | SAM domain binding(GO:0032093) |
0.5 | 11.5 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 5.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 1.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.5 | 15.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.5 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.5 | 12.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 15.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 1.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 2.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 76.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 6.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 3.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 10.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.5 | 4.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 26.0 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 6.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 0.9 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.5 | 6.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 4.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 9.2 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 1.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 10.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 5.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 2.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 7.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.4 | 22.1 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 0.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.4 | 3.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 3.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 3.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 5.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 2.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.4 | 2.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 3.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 9.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 3.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 5.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.2 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.4 | 3.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 2.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 3.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 1.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 24.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 2.6 | GO:0045174 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.4 | 4.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 1.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 8.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 1.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 4.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.4 | 2.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 47.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 3.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.4 | 0.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.4 | 4.2 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.4 | 1.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.4 | 5.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 6.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 4.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.0 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.3 | 3.4 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 5.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 17.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 2.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 3.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.0 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.3 | 5.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.3 | 3.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 3.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 6.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 1.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.3 | 12.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 1.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 1.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.3 | 2.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 6.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 7.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 2.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 5.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 4.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 23.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 2.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 2.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 0.9 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 3.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 3.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 2.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 3.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 0.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 11.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 3.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.8 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.3 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 16.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 3.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 2.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 2.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 2.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 3.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 4.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 3.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.8 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.3 | 2.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.3 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 1.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 9.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 4.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 2.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 3.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 7.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 1.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 17.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 2.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 1.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 3.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 1.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 9.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 11.9 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.2 | 9.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 16.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 2.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 3.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 23.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 2.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.8 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.2 | 3.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.8 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
0.2 | 6.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.8 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.2 | 1.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 0.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.2 | 0.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 2.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 2.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 12.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 2.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 3.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 2.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.7 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.2 | 1.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 4.6 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 5.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 3.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.3 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 6.2 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.1 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 1.5 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 5.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 4.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 3.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.7 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0032357 | oxidized purine DNA binding(GO:0032357) supercoiled DNA binding(GO:0097100) |
0.1 | 1.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0002113 | interleukin-33 binding(GO:0002113) interleukin-33 receptor activity(GO:0002114) |
0.1 | 2.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 0.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 2.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 1.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 3.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.5 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 63.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.2 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.1 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.1 | 26.7 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.1 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 3.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.7 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 17.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 8.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 5.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 4.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 2.6 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.3 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 8.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 3.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 1.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.1 | 2.0 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 4.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 1.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 6.3 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0018271 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.0 | 0.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 20.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 1.7 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 107.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.3 | 44.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.2 | 4.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.9 | 24.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 43.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 6.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 3.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 20.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 54.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 5.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 3.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 21.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.5 | 1.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 16.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 12.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 23.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 111.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 7.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 4.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 9.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 20.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 6.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 12.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 8.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 3.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 9.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 12.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 20.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 5.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 17.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 10.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 4.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 3.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 16.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 7.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 10.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 8.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 9.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 6.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 21.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 15.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 1.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 4.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 3.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 5.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 5.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 6.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 12.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 18.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
4.6 | 69.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
4.3 | 124.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.0 | 41.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.9 | 37.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.8 | 39.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.3 | 45.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.0 | 34.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.0 | 17.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.8 | 1.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
1.7 | 41.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.4 | 17.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.4 | 13.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.3 | 21.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.2 | 14.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.2 | 22.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 18.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.0 | 34.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.0 | 10.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 54.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.0 | 13.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 14.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 21.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 30.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 2.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.9 | 2.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 5.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.8 | 16.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 20.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.8 | 8.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.8 | 63.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 42.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 3.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.7 | 14.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 25.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 30.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 54.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.7 | 6.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 12.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 3.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 11.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 25.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.6 | 121.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.6 | 10.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 32.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 7.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 4.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 3.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 6.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 9.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 35.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 3.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 12.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 10.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 8.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 10.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 9.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 4.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 22.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 2.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 8.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 2.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 1.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.5 | 10.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 17.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 8.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 40.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 5.7 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 4.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 9.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 1.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 3.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 10.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 12.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 4.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 8.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 17.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 11.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 13.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 4.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 5.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 1.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 6.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.3 | 12.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 3.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 1.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.6 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 6.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 6.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 6.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 16.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 4.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 10.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 8.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 1.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 3.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 6.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 5.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 3.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 11.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 9.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 3.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 2.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.7 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 4.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.3 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 3.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 3.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |